ngLVA degradation kinetics. by Nicole A. Grieshaber (11175417)

“…<p>Cos-7 cell infected with L2-euoprom-ngLVA, treated with 34 μg/ml chloramphenicol (CAM) or vehicle only (1:1000 EtOH in RPMI) at 35 hpi (arrow). …”

Baseline level biochemical and circulating biomarkers in study subjects. by Jaskiran Kaur (160829)

Change in serum levels of vitamin D and angiogenic marker at 16 weeks follow-up. by Jaskiran Kaur (160829)

Analytical sensitivity and reproducibility. by Lizhi Yu (12476136)

Subjects:

Depth of coverage and heterogeneity of the mutation loci. x-axis, mutation loci in sample set one or two; y-axis, depth of coverage after UMI consolidation. by Lizhi Yu (12476136)

Subjects:

Reference mutations versus background noise across replicates. by Lizhi Yu (12476136)

Subjects:

Quantification and accuracy of average VAF. by Lizhi Yu (12476136)

Subjects:

Schematic overview of the cross-platform study. by Lizhi Yu (12476136)

Subjects:

Impact of DNA extraction process on depth of coverage. by Lizhi Yu (12476136)

Subjects:

Excision of HIF1α decreases viral reactivation from latency in infected splenocytes in vivo. by Darlah M. López-Rodríguez (8098544)

TBEV-induced translational arrest results in the decreased protein levels of GAPDH, HPRT1, and viperin. by Martin Selinger (3195987)

Modeling methods of included studies (n = 61). by Natalie Riva Smith (13899600)

Populations and outcomes modeled in included studies (n = 61). by Natalie Riva Smith (13899600)

Baseline clinical profile of hospitalized COVID-19 patients with low and high renalase. by Basmah Safdar (12213257)

Sugar-sweetened beverage policies examined by simulation modeling studies (n = 61). by Natalie Riva Smith (13899600)

Bioinformatics analysis of the gene pathways that were enriched in the N.g MDP–treated osteocytes and verification <i>in vitro</i>. by Zheng-Rong Gao (12488388)

“…(G) In vivo, immunohistochemistry showed increased CLOCK expression in bone mesenchymal stem cells (BMSCs) and osteoblasts, but decreased expression in osteocytes. Scale bar = 10 μm. …”

Description of the cohort (N = 118 patients). by Bastien Le Floc’h (14773916)

“…An HLA-G plasma level ≤ 50 ng/ml on day 8 after LT was significantly associated with a higher rejection risk. …”

Dynamic of prolactin in pregnant women during pregnancy. by Francois Kiemde (5369657)

“…Code: *: <0.05; **: <0.01; ***: <0.001; ****: <0.0001. 30μl of plasma was used to determine the concentration of prolactin in blood (ng/ml). Prolactin levels were compared between multigravidae and primigravidae at each scheduled visits as described in “Method” section and presented as box and whisker plots illustration: top, bottom and middle of box, representing 25^th, 75^th and 50^th percentiles, respectively. …”

Dynamics of cortisol levels measured in pregnant women during pregnancy determined at different ANC visits. by Francois Kiemde (5369657)

“…In each case, 30μl of plasma was used to determine for cortisol level in blood (ng/ml). Cortisol levels were compared between multigravidae and primigravidae at each scheduled visits and presented as box and whisker plots illustration: top, bottom and middle of box, representing 25^th, 75^th and 50^th percentiles, respectively. …”

IODVA1 inhibits lamellipodia and circular dorsal ruffle (CDR) formation in MDA-MB-231 cells and decreases Rac activation. by Anjelika Gasilina (8566296)